Summary
Samuel Callisto is a Senior Scientist with nine years of experience specializing in pharmacometrics, population PK/PD modeling, and clinical trial simulation, currently advancing drug development at Metrum Research Group. He combines deep technical skill in NONMEM and R/Tidyverse with an academic perspective as an Adjunct Assistant Professor at the University of Minnesota, translating neuropharmacology and pharmacogenomics research into practical dosing strategies. His PhD work on antiepileptic drugs—modeling cognitive adverse effects and lamotrigine changes in pregnancy—demonstrates a rare blend of clinical insight and quantitative rigor. Known for teaching and continuous learning, he focuses on improving efficiency in bringing therapeutics to market by bridging clinical pharmacology, biostatistics, and software-driven modeling.
9 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (PhD), Experimental and Clinical Pharmacology, Doctor of Philosophy (PhD), Experimental and Clinical Pharmacology at University of Minnesota College of Pharmacy
Bachelor of Arts (BA), Biology, General, Bachelor of Arts (BA), Biology, General at Saint Mary's University of Minnesota